Purpose

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥18 years at the time of consent. - Severe symptomatic tricuspid regurgitation (TR) despite optimal medical therapy (OMT). - Local site multidisciplinary heart team experienced in tricuspid valve therapies agrees that the subject is appropriate for TTVR.

Exclusion Criteria

  • Any tricuspid device currently in place. - Anatomic contraindications. - Need for emergent or urgent surgery. - Left ventricular ejection fraction <25%.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Medtronic Intrepid™ TTVR
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.
  • Device: Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
    Transcatheter Tricuspid Valve Replacement
Active Comparator
Edwards EVOQUE TTVR
Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.
  • Device: Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
    Transcatheter Tricuspid Valve Replacement
Experimental
Single Arm Registry
Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.
  • Device: Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
    Transcatheter Tricuspid Valve Replacement

Recruiting Locations

Abrazo Arizona Heart Hospital
Phoenix, Arizona 85016
Contact:
Jesica Byrne
602-952-0002
jessica.byrne@abrazohealth.com

Los Robles Hospital & Medical Center
Thousand Oaks, California 91360
Contact:
Jason Yashar
805-796-5881
jason.yashar@hcahealthcare.com

Abbott Northwestern Hospital
Minneapolis, Minnesota 55407
Contact:
Jennifer Nguyen
612-863-9291
jennifer.nguyen@allina.com

The Christ Hospital
Cincinnati, Ohio 45219
Contact:
Jamie Elkins
513-585-1640
jamie.elkins@thechristhospital.com

More Details

Status
Recruiting
Sponsor
Medtronic Cardiovascular

Study Contact

Amber St Martin
612-380-5637
rs.pathfinder@medtronic.com

Detailed Description

Prospective, global, pre-market, interventional, multi-center, randomized controlled pivotal trial to evaluate the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System compared to Edwards EVOQUE TTVR System in symptomatic patients with severe or greater tricuspid regurgitation.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.